5.86
+0.43
+(7.92%)
At close: April 11 at 4:00:01 PM EDT
5.85
-0.01
(-0.17%)
After hours: April 11 at 7:59:38 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 5 | 5 | 7 | 6 |
| Avg. Estimate | 0.19 | 0.2 | 0.27 | 0.58 |
| Low Estimate | -0.58 | -0.36 | -1.3 | -1.15 |
| High Estimate | 2.67 | 0.64 | 2.69 | 2.49 |
| Year Ago EPS | -1.05 | 0.99 | -1.23 | 0.27 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 7 | 6 |
| Avg. Estimate | 204.07M | 155.18M | 532.19M | 561.68M |
| Low Estimate | 31.9M | 77M | 325M | 320.58M |
| High Estimate | 601M | 200M | 1.1B | 888.6M |
| Year Ago Sales | 93.86M | 415.48M | 682.16M | 532.19M |
| Sales Growth (year/est) | 117.44% | -62.65% | -21.98% | 5.54% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -1.06 | 1.67 | -0.78 | -0.51 |
| EPS Actual | -1.05 | 0.99 | -0.76 | -0.52 |
| Difference | 0.01 | -0.68 | 0.02 | -0.01 |
| Surprise % | 1.32% | -40.71% | 2.31% | -1.21% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0.19 | 0.2 | 0.27 | 0.58 |
| 7 Days Ago | -0.42 | 0.2 | -0.24 | 0.53 |
| 30 Days Ago | -0.38 | 0.34 | -0.24 | 0.53 |
| 60 Days Ago | -0.49 | 0.65 | 0.11 | 1.41 |
| 90 Days Ago | -0.49 | 0.65 | 0.11 | 1.41 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | 1 | 1 | 1 |
| Up Last 30 Days | 1 | -- | 2 | 1 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | 1 | -- | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| NVAX | 151.75% | -82.15% | 108.62% | 263.21% |
| S&P 500 | 6.43% | 6.13% | 9.43% | 14.26% |
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Buy to Buy | 12/10/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 11/13/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 11/12/2024 |
| Reiterates | B. Riley Securities: Buy to Buy | 8/12/2024 |
| Maintains | JP Morgan: Underweight to Underweight | 8/12/2024 |
| Maintains | B. Riley Securities: Buy to Buy | 8/2/2024 |
Related Tickers
MRNA Moderna, Inc.
26.20
+6.94%
TNXP Tonix Pharmaceuticals Holding Corp.
16.88
-2.43%
SMMT Summit Therapeutics Inc.
23.24
+15.33%
RXRX Recursion Pharmaceuticals, Inc.
5.76
+27.72%
SXTP 60 Degrees Pharmaceuticals, Inc.
2.9600
-4.52%
IBO Impact BioMedical Inc.
0.4951
-2.92%
PHIO Phio Pharmaceuticals Corp.
1.7400
+5.45%
VKTX Viking Therapeutics, Inc.
22.22
+3.25%
BNTX BioNTech SE
96.52
+3.65%
RYTM Rhythm Pharmaceuticals, Inc.
59.55
+2.97%